Is CCEL (CCEL) Halal?

AMEX Healthcare United States $27M
✗ NOT HALAL
Confidence: 90/100
CCEL (CCEL) is Not Halal under AAOIFI Standard 21. The company's debt ratio of 49.6% exceeds the 30% threshold, indicating excessive interest-bearing debt relative to market capitalization. CCEL operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from November 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 49.6%
/ 30%
13.4%
/ 30%
28.0%
/ 30%
2.74%
/ 5%
✗ NOT HALAL
DJIM 49.6%
/ 33%
13.4%
/ 33%
28.0%
/ 33%
2.74%
/ 5%
✗ NOT HALAL
MSCI 20.0%
/ 33%
5.4%
/ 33%
11.3%
/ 33%
2.74%
/ 5%
✓ HALAL
S&P 49.6%
/ 33%
13.4%
/ 33%
28.0%
/ 33%
2.74%
/ 5%
✗ NOT HALAL
FTSE 20.0%
/ 33%
5.4%
/ 33%
11.3%
/ 50%
2.74%
/ 5%
✓ HALAL

Financial Highlights

EPS
$-0.30
Dividend Yield
1813.0%
Payout: 3962.9%
P/B Ratio
-1.4
EV/EBITDA
23.8
EV: $35M
Revenue
$32M
Growth: -2.3%
Beta
0.7
Low volatility
Current Ratio
0.6

Profitability

Gross Margin 62.8%
Operating Margin -50.6%
Net Margin -7.7%
Return on Assets (ROA) 0.5%

Cash Flow & Balance Sheet

Operating Cash Flow$5M
Free Cash Flow$5M
Total Debt$12M
Current Ratio0.6
Total Assets$62M

Price & Trading

Last Close$3.25
50-Day MA$3.29
200-Day MA$4.16
Avg Volume15K
Beta0.7
52-Week Range
$2.72
$6.65

About CCEL (CCEL)

CEO
Mr. David I. Portnoy
Employees
72
Sector
Healthcare
Industry
Medical Care Facilities
Country
United States
Exchange
AMEX
Market Cap
$27M
Currency
USD

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is CCEL (CCEL) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), CCEL is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is CCEL's debt ratio?

CCEL's debt ratio is 49.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 20.0%.

What are CCEL's key financial metrics?

CCEL has a market capitalization of $27M, and revenue of $32M. The company maintains a gross margin of 62.8% and a net margin of -7.7%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.